NGLCD | LFD | |||||
---|---|---|---|---|---|---|
Baseline | 12 months | Mean change | Baseline | 12 months | Mean change | |
FPG (mg/dl) | 104.1 ± 27.9 | 96.9 ± 19.7 | −7.2 ± 11.2 [−10.2, - 4.2] | 103.7 ± 29.2 | 96.5 ± 19.1 | −7.2 ± 13.1* [−10.8, -3.5] |
FPI (μU/ml) | 14.2 (11.5-21.8) | 9.1 (6.2-16.9) | −7.6 ± 11.5* [−10.7, -4.6] | 12.8 (8.7-18.8) | 9.15 (6.06-17.08) | −5.2 ± 9.2* [−7.8, -2.6] |
HOMA-IR | 3.33 (2.3-5.9) | 1.99 (1.45-4.04) | −2.4 ± 4.1 * [−3.5, -1.3] | 3.06 (1.93-5.11) | 2.04 (1.3-4.4) | −1.8 ± 3.9* [−2.9, -0.7] |
C Peptide (ng/ml) | 2.31 (2.01-2.8) | 2.34 (2.08-2.9) | −0.03-0.2 ** [−0.09, -0.03] | 2.4 (2.07-2.97) | 2.41 (2.1-3.1) | −0.002 ± 0.2*** [−0.004, 0.01] |
HbA1c (%) | 5.7 ± 0.7 | 5.6 ± 0.7 | −0.11 ± 0.3 * [−0.02, -0.2] | 5.6 ± 0.5 | 5.5 ± 0.5 | −0.09 ± 0.2* [−0.06, 0.05] |